ArticleClinical proteomics2024

Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary Disease.

Sonu Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.